nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A call for reforms in global health publications
|
Sharma, Dhananjaya |
|
|
9 |
7 |
p. e901-e902 |
artikel |
2 |
An investment case for the prevention and management of rheumatic heart disease in the African Union 2021–30: a modelling study
|
Coates, Matthew M |
|
|
9 |
7 |
p. e957-e966 |
artikel |
3 |
Association between medical male circumcision and HIV risk compensation among heterosexual men: a systematic review and meta-analysis
|
Gao, Yanxiao |
|
|
9 |
7 |
p. e932-e941 |
artikel |
4 |
Communicable and non-communicable diseases coexisting in South Africa
|
Modjadji, Perpetua |
|
|
9 |
7 |
p. e889-e890 |
artikel |
5 |
Convergence of infectious and non-communicable disease epidemics in rural South Africa: a cross-sectional, population-based multimorbidity study
|
Wong, Emily B |
|
|
9 |
7 |
p. e967-e976 |
artikel |
6 |
Correction to Lancet Glob Health 2021; 9: e908–09
|
|
|
|
9 |
7 |
p. e915 |
artikel |
7 |
Correction to Lancet Glob Health 2021; 9: e366–71
|
|
|
|
9 |
7 |
p. e915 |
artikel |
8 |
Correction to Lancet Glob Health 2021; published online March 22. https://doi.org/10.1016/S2214-109X(21)00059-0
|
|
|
|
9 |
7 |
p. e915 |
artikel |
9 |
Correction to Lancet Glob Health 2021; 9 (suppl 1): S16
|
|
|
|
9 |
7 |
p. e915 |
artikel |
10 |
COVID-19 reinfections in The Gambia by phylogenetically distinct SARS-CoV-2 variants—first two confirmed events in west Africa
|
Sanyang, Bakary |
|
|
9 |
7 |
p. e905-e907 |
artikel |
11 |
Does medical male circumcision result in sexual risk compensation in Africa?
|
Serwadda, David Musoke |
|
|
9 |
7 |
p. e883-e884 |
artikel |
12 |
Estimating and mitigating the risk of COVID-19 epidemic rebound associated with reopening of international borders in Vietnam: a modelling study
|
Pham, Quang D |
|
|
9 |
7 |
p. e916-e924 |
artikel |
13 |
Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study
|
Debellut, Frédéric |
|
|
9 |
7 |
p. e942-e956 |
artikel |
14 |
Evidence-based medicine in low-income and middle-income countries
|
Adhikari, Sudeep |
|
|
9 |
7 |
p. e903-e904 |
artikel |
15 |
Global health in low-income and middle-income countries: a framework for action
|
Olufadewa, Isaac |
|
|
9 |
7 |
p. e899-e900 |
artikel |
16 |
Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006–18: prospective observational time-series and case-control studies
|
Bar-Zeev, Naor |
|
|
9 |
7 |
p. e989-e998 |
artikel |
17 |
Impact of PCV13 vaccination in Blantyre, Malawi
|
Kamthunzi, Portia |
|
|
9 |
7 |
p. e893-e894 |
artikel |
18 |
Integrated multidisciplinary post-COVID-19 care in Egypt
|
Aiash, Hani |
|
|
9 |
7 |
p. e908-e909 |
artikel |
19 |
Lessons in humility
|
The Lancet Global Health, |
|
|
9 |
7 |
p. e880 |
artikel |
20 |
Operation Warp Speed: implications for global vaccine security
|
|
|
|
9 |
7 |
p. e1017-e1021 |
artikel |
21 |
Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study
|
Kande Betu Ku Mesu, Victor |
|
|
9 |
7 |
p. e999-e1008 |
artikel |
22 |
Partner-delivered HIV self-test kits with and without financial incentives in antenatal care and index patients with HIV in Malawi: a three-arm, cluster-randomised controlled trial
|
Choko, Augustine T |
|
|
9 |
7 |
p. e977-e988 |
artikel |
23 |
Reaching the theoretical herd immunity threshold in Iquitos, Peru: are seroprevalence data enough?
|
Chenet, Stella M |
|
|
9 |
7 |
p. e881-e882 |
artikel |
24 |
Resetting the agenda for antibiotic resistance through a health systems perspective
|
Cars, Otto |
|
|
9 |
7 |
p. e1022-e1027 |
artikel |
25 |
Rotavirus vaccine implementation: evidence to fill the gap?
|
Buttery, Jim P |
|
|
9 |
7 |
p. e885-e886 |
artikel |
26 |
Safety and efficacy of rituximab in Malawi: a case for multicentre oncology clinical trials in Africa?
|
Mbulaiteye, Sam M |
|
|
9 |
7 |
p. e895-e896 |
artikel |
27 |
Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial
|
Kimani, Stephen |
|
|
9 |
7 |
p. e1008-e1016 |
artikel |
28 |
Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study
|
Álvarez-Antonio, Carlos |
|
|
9 |
7 |
p. e925-e931 |
artikel |
29 |
Setting the record straight on measuring SDG 4.2.1
|
Hereward, Mark |
|
|
9 |
7 |
p. e910-e911 |
artikel |
30 |
Setting the record straight on measuring SDG 4.2.1 – Authors' reply
|
Olusanya, Bolajoko O |
|
|
9 |
7 |
p. e912 |
artikel |
31 |
Targeted investment needed to end rheumatic heart disease in Africa
|
Okello, Emmy |
|
|
9 |
7 |
p. e887-e888 |
artikel |
32 |
The secondary distribution of HIV self-testing kits
|
Mweemba, Oliver |
|
|
9 |
7 |
p. e891-e892 |
artikel |
33 |
The words we choose matter: recognising the importance of language in decolonising global health
|
Hommes, Franziska |
|
|
9 |
7 |
p. e897-e898 |
artikel |
34 |
Visual function rather than visual acuity
|
Murdoch, Ian |
|
|
9 |
7 |
p. e913 |
artikel |
35 |
Visual function rather than visual acuity – Authors' reply
|
Kyari, Fatima |
|
|
9 |
7 |
p. e914 |
artikel |